254 related articles for article (PubMed ID: 35182815)
1. Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach.
Tawfik HO; Petreni A; Supuran CT; El-Hamamsy MH
Eur J Med Chem; 2022 Mar; 232():114190. PubMed ID: 35182815
[TBL] [Abstract][Full Text] [Related]
2. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
3. Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.
Hou Z; Lin B; Bao Y; Yan HN; Zhang M; Chang XW; Zhang XX; Wang ZJ; Wei GF; Cheng MS; Liu Y; Guo C
Eur J Med Chem; 2017 May; 132():1-10. PubMed ID: 28334643
[TBL] [Abstract][Full Text] [Related]
4. Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors.
Ahmed RF; Mahmoud WR; Abdelgawad NM; Fouad MA; Said MF
Eur J Med Chem; 2023 Dec; 261():115805. PubMed ID: 37748386
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
[TBL] [Abstract][Full Text] [Related]
6. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
8. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT
Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409
[TBL] [Abstract][Full Text] [Related]
9. Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: Synthesis, cytotoxicity, and molecular modelling studies.
Demir-Yazıcı K; Trawally M; Bua S; Öztürk-Civelek D; Akdemir A; Supuran CT; Güzel-Akdemir Ö
Bioorg Chem; 2024 Mar; 144():107096. PubMed ID: 38290186
[TBL] [Abstract][Full Text] [Related]
10. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
11. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
12. Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents.
Tawfik HO; Belal A; Abourehab MAS; Angeli A; Bonardi A; Supuran CT; El-Hamamsy MH
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2765-2785. PubMed ID: 36210545
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity.
Abdelhakeem MM; Morcoss MM; Hanna DA; Lamie PF
Bioorg Chem; 2024 Mar; 144():107154. PubMed ID: 38309003
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307
[TBL] [Abstract][Full Text] [Related]
15. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
17. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
18. Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors.
Kumar A; Siwach K; Rom T; Kumar R; Angeli A; Kumar Paul A; Supuran CT; Sharma PK
Bioorg Chem; 2022 Jun; 123():105764. PubMed ID: 35366582
[TBL] [Abstract][Full Text] [Related]
19. Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights.
Abdelrahman MA; Eldehna WM; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137489
[TBL] [Abstract][Full Text] [Related]
20. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
